exacerbations

July 27, 2017July 27, 2017

Survey Seeks to Better Understand Psychological Burden Associated with IPF

Patients with idiopathic pulmonary fibrosis (IPF) frequently experience anxiety, fear, uncertainty, hopelessness, and limitations in daily activities, according to a global survey conducted by the pharmaceutical company Boehringer Ingelheim. “We know ... Read more

March 1, 2017March 16, 2017

Aerobika Device Reduces Number of COPD Flare-ups, Study Shows

COPD, News

The Aerobika device significantly reduced flare-ups of chronic obstructive pulmonary disease (COPD) in the 30 days after patients had emergency room visits or were re-hospitalized after a previous flare-up, a study shows. ... Read more

November 30, 2016November 30, 2016

Smartinhaler Use Helps Children with Severe Asthma Stay with Treatments, Study Finds

Asthma, News

Adherium Limited announced promising results from a clinical trial evaluating the use of Smartinhaler, its respiratory disease management tool, in children with poorly controlled asthma. Over 12 months, Smartinhaler use was seen to significantly reduce ... Read more

November 7, 2016November 7, 2016

Research Team Will Collaborate to Study Underlying Causes of Asthma Exacerbations

Asthma, News

Owlstone Medical and Imperial College London recently announced the establishment of a new collaboration to study the underlying causes of exacerbations in people with severe asthma. The World Health Organization (WHO) estimates ... Read more

August 23, 2016August 23, 2016

Cinqaero (Reslizumab) for Severe Asthma Granted EC Marketing Authorization

Asthma, News

The European Commission (EC) has granted marketing authorization for Teva Pharmaceutical’s Cinqaero (reslizumab) in all European Union (EU) nations, Norway, Liechtenstein, and Iceland. The therapy treats inadequately controlled asthma in adult and ... Read more

August 12, 2016August 12, 2016

Better Combination Therapy Appears More Effective for COPD Exacerbations, Study Finds

COPD, News

Results from a recent clinical trial demonstrated that treatment with the combination bronchodilator and inhaled medicine therapy indacaterol/glycopyrronium is better for treating chronic obstructive pulmonary disorder (COPD) exacerbations. The study, ... Read more

July 12, 2016July 12, 2016

FDA Approves Xolair for Allergic Pediatric Asthma

Asthma, News

Genentech recently announced that the U.S. Food and Drug Administration (FDA) approved Xolair (omalizumab) for the treatment of persistent allergic asthma in children aged 6 to 11 years old. Xolair therapy was already ... Read more

July 11, 2016July 11, 2016

NebuTech Nebulizer Seen to Shorten Emergency Room Stays for Children with Asthma Flares

Asthma, COPD, News

A clinical study comparing the NebuTech nebulizer, developed by Salter Labs, and a standard nebulizer found that pediatric asthma patients using the newer device had a nearly 45-minute reduction in emergency-room hospital stays. Results of ... Read more

June 24, 2016June 24, 2016

Novartis Trial Assesses Ultibro Breezhaler For COPD Flare-Ups

COPD, News

Novartis recently announced encouraging data from a clinical trial evalutating the efficacy of once-daily Ultibro Breezhaler (indacaterol/glycopyrronium bromide) for reducing chronic obstructive pulmonary disease (COPD) flare-ups. The report was published in the New England ... Read more

June 1, 2016June 3, 2016

Salford Lung Study Shows Reduction in COPD Exacerbations with Relvar Ellipta

COPD, News

GlaxoSmithKline reported positive results from the pioneering Salford Lung Study (SLS) evaluating Relvar Ellipta 100/25 mcg for the treatment of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Relvar is ... Read more